Clinical and bacteriological effectiveness of three different short-course antibiotic regimens and single-dose fosfomycin for uncomplicated lower urinary tract infections in women (SCOUT): a pragmatic, multicentre, open-label, randomised clinical trial

2026/04/01 by Carl Llor, Ramon Monfà, Ana Garcia-Sangenís +13 · 1 voice
Immunology and Microbiology · Medicine · #Bladder and Urothelial Cancer Treatments #Reproductive tract infections research #Urinary Tract Infections Management

paper · doi:10.1016/s0140-6736(25)02171-3

crossref issued 2026/04/01 · crossref published 2026/04/01 · crossref published-print 2026/04/01 · openalex publication_date 2026/04/01 · crossref created 2026/04/20 · openalex created_date 2026/04/21 · crossref deposited 2026/07/03 · crossref indexed 2026/07/09 · openalex updated_date 2026/07/22

Citations

• Safety and Tolerability of Pivmecillinam During More Than Four Decades of Clinical Experience: A Systematic Review
• State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women

Discussions

• 📄 Publicamos en The Lancet el ensayo SCOUT en 768 mujeres con cistitis no complicada. Nitrofurantoína fue la más eficaz (74%), fosfomicina dosis única la peor (59%). Podría replantearse su uso como p [bsky, 0 points, 0 comments]